Zhixiang Jian

1.2k citations
38 papers · 781 indexed · h-index 17
Topics
Hepatocellular Carcinoma Treatment and Prognosis (12 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers)Pancreatic and Hepatic Oncology Research (9 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Zhixiang Jian

38 papers receiving 770 citations

Peers

Zhixiang Jian
Comparison fields: 5 of 70
  • Oncology 335
  • Surgery 231
  • Pulmonary and Respiratory Medicine 211
  • Molecular Biology 206
  • Hepatology 195
Replace Mariko Tsukagoshi with:
Mariko Tsukagoshi Japan
Takayoshi Kaida Japan
Kohei Shigeta Japan
Norihiro Ishii Japan
Takamichi Igarashi Japan
Monica Lencioni Italy
Kyohei Yugawa Japan
Tsukasa Takayashiki Japan
Sang Soo Kim South Korea
N. Chatzizacharias United Kingdom
Zhixiang Jian relative to Mariko Tsukagoshi Japan Mariko Tsukagoshi's profile →
Citations per field
00.5×1.5×
Mariko Tsukagoshi · 1×
Citations per year

Countries citing papers authored by Zhixiang Jian

Since Specialization
Citations

This map shows the geographic impact of Zhixiang Jian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixiang Jian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixiang Jian more than expected).

Fields of papers citing papers by Zhixiang Jian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixiang Jian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixiang Jian. The network helps show where Zhixiang Jian may publish in the future.

Co-authorship network of co-authors of Zhixiang Jian

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixiang Jian. A scholar is included among the top collaborators of Zhixiang Jian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixiang Jian. Zhixiang Jian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 33
3 13
4 5
5 3
6 9
7 9
8 14
9 3
10 8
11 27
12 10
13 10
14 25
15 27
16 10
17 5
18 18
19 12
20 55

About Zhixiang Jian

Zhixiang Jian is a scholar working on Hepatology, Oncology and Cancer Research, having authored 38 papers that have together received 781 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Pancreatic and Hepatic Oncology Research (9 papers). The work is most often cited by research in Hepatology (195 citations), Oncology (335 citations) and Cancer Research (180 citations). Zhixiang Jian has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Haosheng Jin, Ye Lin, Min Yu, Baohua Hou, Zi Yin, Liang Chang, Renguo Guan, Shiye Ruan, Yiping Zou and Weifeng Hong. Their work appears in journals such as Frontiers in Immunology, Medicine and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026